Literature DB >> 22693285

Delineation of CCDC39/CCDC40 mutation spectrum and associated phenotypes in primary ciliary dyskinesia.

Sylvain Blanchon1, Marie Legendre, Bruno Copin, Philippe Duquesnoy, Guy Montantin, Esther Kott, Florence Dastot, Ludovic Jeanson, Marine Cachanado, Alexandra Rousseau, Jean François Papon, Nicole Beydon, Jacques Brouard, Bruno Crestani, Antoine Deschildre, Julie Désir, Hélène Dollfus, Bruno Leheup, Aline Tamalet, Caroline Thumerelle, Anne-Marie Vojtek, Denise Escalier, André Coste, Jacques de Blic, Annick Clément, Estelle Escudier, Serge Amselem.   

Abstract

BACKGROUND: CCDC39 and CCDC40 genes have recently been implicated in primary ciliary dyskinesia (PCD) with inner dynein arm (IDA) defects and axonemal disorganisation; their contribution to the disease is, however, unknown. Aiming to delineate the CCDC39/CCDC40 mutation spectrum and associated phenotypes, this study screened a large cohort of patients with IDA defects, in whom clinical and ciliary phenotypes were accurately described.
METHODS: All CCDC39 and CCDC40 exons and intronic boundaries were sequenced in 43 patients from 40 unrelated families. The study recorded and compared clinical features (sex, origin, consanguinity, laterality defects, ages at first symptoms and at phenotype evaluation, neonatal respiratory distress, airway infections, nasal polyposis, otitis media, bronchiectasis, infertility), ciliary beat frequency, and quantitative ultrastructural analyses of cilia and sperm flagella.
RESULTS: Biallelic CCDC39 or CCDC40 mutations were identified in 30/34 (88.2%) unrelated families with IDA defects associated with axonemal disorganisation (22 and eight families, respectively). Fourteen of the 28 identified mutations are novel. No mutation was found in the six families with isolated IDA defects. Patients with identified mutations shared a similar phenotype, in terms of both clinical features and ciliary structure and function. The sperm flagellar ultrastructure, analysed in 4/7 infertile males, showed evidence of abnormalities similar to the ciliary ones.
CONCLUSIONS: CCDC39 and CCDC40 mutations represent the major cause of PCD with IDA defects and axonemal disorganisation. Patients carrying CCDC39 or CCDC40 mutations are phenotypically indistinguishable. CCDC39 and CCDC40 analyses in selected patients ensure mutations are found with high probability, even if clinical or ciliary phenotypes cannot prioritise one analysis over the other.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22693285     DOI: 10.1136/jmedgenet-2012-100867

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  38 in total

Review 1.  Expanding horizons: ciliary proteins reach beyond cilia.

Authors:  Shiaulou Yuan; Zhaoxia Sun
Journal:  Annu Rev Genet       Date:  2013-09-06       Impact factor: 16.830

Review 2.  Gene mutations in primary ciliary dyskinesia related to otitis media.

Authors:  Manuel Mata; Lara Milian; Miguel Armengot; Carmen Carda
Journal:  Curr Allergy Asthma Rep       Date:  2014-03       Impact factor: 4.806

Review 3.  Value of transmission electron microscopy for primary ciliary dyskinesia diagnosis in the era of molecular medicine: Genetic defects with normal and non-diagnostic ciliary ultrastructure.

Authors:  Adam J Shapiro; Margaret W Leigh
Journal:  Ultrastruct Pathol       Date:  2017-09-15       Impact factor: 1.094

4.  Primary Ciliary Dyskinesia (PCD): A genetic disorder of motile cilia.

Authors:  Margaret W Leigh; Amjad Horani; BreAnna Kinghorn; Michael G O'Connor; Maimoona A Zariwala; Michael R Knowles
Journal:  Transl Sci Rare Dis       Date:  2019-07-04

5.  The nexin-dynein regulatory complex subunit DRC1 is essential for motile cilia function in algae and humans.

Authors:  Maureen Wirschell; Heike Olbrich; Claudius Werner; Douglas Tritschler; Raqual Bower; Winfield S Sale; Niki T Loges; Petra Pennekamp; Sven Lindberg; Unne Stenram; Birgitta Carlén; Elisabeth Horak; Gabriele Köhler; Peter Nürnberg; Gudrun Nürnberg; Mary E Porter; Heymut Omran
Journal:  Nat Genet       Date:  2013-01-27       Impact factor: 38.330

6.  Coiled-coil domain containing 42 (Ccdc42) is necessary for proper sperm development and male fertility in the mouse.

Authors:  Raymond C Pasek; Erik Malarkey; Nicolas F Berbari; Neeraj Sharma; Robert A Kesterson; Laura L Tres; Abraham L Kierszenbaum; Bradley K Yoder
Journal:  Dev Biol       Date:  2016-03-03       Impact factor: 3.582

7.  A novel DNAH5 variant in a Tunisian patient with primary ciliary dyskinesia.

Authors:  Rahma Mani; JihèNe Bouguila; Salma Ben Ameur; Mongia Hachicha; Zohra Soua; Imed Mabrouk
Journal:  J Genet       Date:  2020       Impact factor: 1.166

Review 8.  The evolving spectrum of ciliopathies and respiratory disease.

Authors:  Carlos E Milla
Journal:  Curr Opin Pediatr       Date:  2016-06       Impact factor: 2.856

9.  European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia.

Authors:  Jane S Lucas; Angelo Barbato; Samuel A Collins; Myrofora Goutaki; Laura Behan; Daan Caudri; Sharon Dell; Ernst Eber; Estelle Escudier; Robert A Hirst; Claire Hogg; Mark Jorissen; Philipp Latzin; Marie Legendre; Margaret W Leigh; Fabio Midulla; Kim G Nielsen; Heymut Omran; Jean-Francois Papon; Petr Pohunek; Beatrice Redfern; David Rigau; Bernhard Rindlisbacher; Francesca Santamaria; Amelia Shoemark; Deborah Snijders; Thomy Tonia; Andrea Titieni; Woolf T Walker; Claudius Werner; Andrew Bush; Claudia E Kuehni
Journal:  Eur Respir J       Date:  2017-01-04       Impact factor: 16.671

10.  Exome sequencing identifies mutations in CCDC114 as a cause of primary ciliary dyskinesia.

Authors:  Michael R Knowles; Margaret W Leigh; Lawrence E Ostrowski; Lu Huang; Johnny L Carson; Milan J Hazucha; Weining Yin; Jonathan S Berg; Stephanie D Davis; Sharon D Dell; Thomas W Ferkol; Margaret Rosenfeld; Scott D Sagel; Carlos E Milla; Kenneth N Olivier; Emily H Turner; Alexandra P Lewis; Michael J Bamshad; Deborah A Nickerson; Jay Shendure; Maimoona A Zariwala
Journal:  Am J Hum Genet       Date:  2012-12-20       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.